Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (71-80 of 300) with videos related to

Pageof 30
Sort By:
British Journal of Clinical Pharmacology|March 26, 2008
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjectsAnton L Pozniak, Marta Boffito, Deborah Russell, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2026
Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?Dela Wordi, Hong-Tham Nguyen, Françoise Livio, et al.
Journal of the International AIDS Society|November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitorTristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.
Therapeutic Drug Monitoring|February 10, 2016
A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV DetectionXinzhu Wang, Sujan Dilly Penchala, Alieu Amara, et al.
The Lancet. HIV|March 19, 2022
Delivering specialised care to people ageing with HIV in the UK: experience and evolution of services from 2009 to 2019Ana Milinkovic, Branca Pereira, Maria Mazziteli, et al.
Journal of the International AIDS Society|November 15, 2014
Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitorsTristan J Barber, Graeme Moyle, Andrew Hill, et al.
AIDS (London, England)|July 2, 2005
Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trialDesmond Maitland, Graeme Moyle, James Hand, et al.
International Journal of STD & AIDS|April 5, 2022
Correlation between different equations to calculate free testosterone for improved detection of hypogonadism in people living with HIVShuang Wu, Orla Hilton, Branca Pereira, et al.
AIDS (London, England)|November 26, 2019
Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIVMaria Mazzitelli, Ana Milinkovic, Branca Pereira, et al.
International Journal of Antimicrobial Agents|April 20, 2019
Pharmacokinetics of dolutegravir 100 mg once daily with rifampicinXinzhu Wang, Maddalena Cerrone, Francesca Ferretti, et al.
Pageof 30

Showing results (71-80 of 300) with videos related to

Sort By:
Pageof 30
British Journal of Clinical Pharmacology|March 26, 2008
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjectsAnton L Pozniak, Marta Boffito, Deborah Russell, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 6, 2026
Therapeutic drug monitoring of letermovir in allogeneic hematopoietic cell transplant recipients: where are we?Dela Wordi, Hong-Tham Nguyen, Françoise Livio, et al.
Journal of the International AIDS Society|November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitorTristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.
Therapeutic Drug Monitoring|February 10, 2016
A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV DetectionXinzhu Wang, Sujan Dilly Penchala, Alieu Amara, et al.
The Lancet. HIV|March 19, 2022
Delivering specialised care to people ageing with HIV in the UK: experience and evolution of services from 2009 to 2019Ana Milinkovic, Branca Pereira, Maria Mazziteli, et al.
Journal of the International AIDS Society|November 15, 2014
Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitorsTristan J Barber, Graeme Moyle, Andrew Hill, et al.
AIDS (London, England)|July 2, 2005
Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trialDesmond Maitland, Graeme Moyle, James Hand, et al.
International Journal of STD & AIDS|April 5, 2022
Correlation between different equations to calculate free testosterone for improved detection of hypogonadism in people living with HIVShuang Wu, Orla Hilton, Branca Pereira, et al.
AIDS (London, England)|November 26, 2019
Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIVMaria Mazzitelli, Ana Milinkovic, Branca Pereira, et al.
International Journal of Antimicrobial Agents|April 20, 2019
Pharmacokinetics of dolutegravir 100 mg once daily with rifampicinXinzhu Wang, Maddalena Cerrone, Francesca Ferretti, et al.
Pageof 30